首页> 外文期刊>Veterinary Parasitology >Nematode burdens of pastured cattle treated once at turnout with eprinomectin extended-release injection
【24h】

Nematode burdens of pastured cattle treated once at turnout with eprinomectin extended-release injection

机译:厄普连菌素缓释注射液一次处理放牧牛的线虫负担

获取原文
获取原文并翻译 | 示例
       

摘要

The efficacy of eprinomectin in an extended-release injection (ERI) formulation was evaluated against infections with third-stage larvae or eggs of gastrointestinal and pulmonary nematodes in cattle under 120-day natural challenge conditions in a series of five studies conducted in the USA (three studies) and in Europe (two studies). For each study, 30 nematode-free (four studies) or 30 cattle harboring naturally acquired nematode infections (one study) were included. The cattle were of various breeds or crosses, weighed 107.5-273 kg prior to treatment and aged approximately 4-11 months. For each study, animals were blocked based on pre-treatment bodyweight and then randomly allocated to treatment: ERI vehicle (control) at 1 mL/50 kg bodyweight or Eprinomectin 5% (w/v) ERI at 1 mL/50 kg bodyweight (1.0 mg eprinomectin/kg) for a total of 15 and 15 animals in each group. Treatments were administered once on Day 0 by subcutaneous injection in front of the shoulder. In each study, all animals grazed one naturally contaminated pasture for 120 days. At regular intervals during the studies, fecal samples from all cattle were examined for nematode egg and larval counts. In four studies pairs of tracer cattle were used to monitor pasture infectivity at 28-day intervals before and/or during the grazing period. All calves were weighed before turnout onto pasture and at regular intervals until housing on Day 120. For parasite recovery, all study animals were humanely euthanized 27-30 days after removal from pasture. Cattle treated with Eprinomectin ERI had significantly (p < 0.05) fewer strongylid eggs (<= 1 egg per gram; egg count reduction >= 94%) than the control cattle and zero lungworm larvae at each post-treatment time point. At euthanasia, cattle treated with Eprinomectin ERI had significantly (p < 0.05) fewer of the following nematodes than the ERI vehicle: treated (control) cattle with overall reduction of nematode counts by >92%: Dictyocaulus viviparus (adults and fourth-stage larvae (L4), Bunostomum phlebotomum, Cooperia curticei, Cooperia oncophora, Cooperia punctata, Cooperia surnabada, Cooperia spp. inhibited L4, Haemonchus contortus, Haemonchus placei, Haemonchus spp. inhibited L4, Nematodirus helvetianus, Nematodirus spp. inhibited L4, Oesophagostomum radiatum, Oesophagostomum spp. inhibited L4, Ostertagia leptospicularis, Ostertagia lyrata, Ostertagia ostertagi, Ostertagia spp. inhibited L4, Trichostrongylus axei, Trichostrongylus colubriformis, Trichostrongylus spp. inhibited L4, Trichuris discolor, and Trichuris ovis. Over the 120-day grazing period, Eprinomectin ERI-treated cattle gained between 4.8 kg and 31 kg more weight than the controls. This weight gain advantage was significant (p < 0.05) in three studies. All animals accepted the treatment well. No adverse reaction to treatment was observed in any animal in any study
机译:在美国进行的五项研究中,评估了在120天自然攻击条件下,依普利菌素在缓释注射液(ERI)制剂中对牛的胃肠道和肺线虫的第三阶段幼虫或卵的感染的疗效(三项研究)和欧洲(两项研究)。对于每项研究,均包括30例无线虫的动物(4项研究)或30具自然获得的线虫感染的牛(一项研究)。这些牛有不同的品种或杂交,在治疗前体重为107.5-273千克,年龄约为4-11个月。对于每项研究,均根据治疗前的体重对动物进行封锁,然后将其随机分配至治疗:1 mL / 50 kg体重的ERI媒介物(对照)或1 mL / 50 kg体重的Eprinomectin 5%(w / v)ERI( 1.0 mg eprinomectin / kg),每组总共15只和15只动物。在第0天通过在肩前皮下注射进行一次治疗。在每项研究中,所有动物都放牧了一个自然污染的牧场120天。在研究期间定期检查所有牛粪便中的线虫卵和幼虫计数。在四项研究中,在放牧期之前和/或期间,以每28天间隔对成对的示踪牛监测牧场的感染性。将所有犊牛称重,然后转入牧场,并定期进行饲养,直到在第120天饲养为止。为了恢复寄生虫,将所有研究动物从牧场中移出后27-30天进行人道安乐死。在每个治疗后的时间点,用埃普里菌素ERI处理的牛的强卵卵(<= 1个鸡蛋/克;卵数减少> = 94%)比对照组牛和零个肺虫幼虫显着(p <0.05)少。在安乐死时,用Eprinomectin ERI治疗的牛的线虫数量比ERI媒介物少(p <0.05):经处理(对照)的牛的线虫总数减少了92%以上:ic虫(成虫和第四阶段幼虫) (L4),牛膝草,库珀库珀,库珀oncophora,库珀点,库珀surnabada,库珀spp。抑制L4,弯孢Haemonchus contortus,弯孢菌Placei,弯孢属spp.sup。L4,线虫,线虫L. spp。抑制L4,扁球形的Ostertagia,Ostertagia lyrata,stersteria ostertagi,Ostertagia pp。经处理的牛比对照组增加了4.8公斤至31公斤的体重,这种增重优势非常明显(p <0.0 5)在三个研究中。所有动物都很好地接受了治疗。在任何研究中,任何动物均未观察到对治疗的不良反应

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号